nitazoxanide: Clinical Trials

6 trials of nitazoxanide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Terminated 6
Phase 22Terminated 2

Follow nitazoxanide: new trials by email Literature Review of nitazoxanide trials Research Report on nitazoxanide

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Catalysing the Containment of COVID-19
Nitazoxanide, Placebo - COVID-19
Phase 2 / Phase 3TerminatedUniversity of Cape Town3222020-08-272022-08-16
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Nitazoxanide, Placebo, Vitamin Super B-Complex - Enterovirus, Rhinovirus
Phase 3TerminatedRomark Laboratories L.C.2142020-08-192024-10-17
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)
Nitazoxanide, Placebo, Vitamin Super B-Complex - COVID-19, Viral Respiratory Illnesses
Phase 3TerminatedRomark Laboratories L.C.1902020-05-122024-07-08
Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children
Nitazoxanide, placebo - Gastroenteritis
Phase 2 / Phase 3TerminatedTelethon Kids Institute2162014-11-012024-02-08
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
Nitazoxanide, Vancomycin - Clostridium Infections
Phase 3TerminatedRomark Laboratories L.C.502006-12-012015-05-05
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
Nitazoxanide - Cryptosporidiosis, HIV Infections
Phase 3TerminatedRomark Laboratories L.C.302000-02-012005-06-24

Conditions studied

COVID-19 (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Clostridium Infections (1)  ·  Cryptosporidiosis (1)  ·  Enterovirus Infections (1)  ·  Gastroenteritis (1)  ·  HIV Infections (1)

Sponsors

Romark Laboratories L.C. (4)  ·  Telethon Kids Institute (1)  ·  University of Cape Town (1)

Countries

United States (4)  ·  Australia (1)  ·  South Africa (1)

Top investigators

Adam Bressler, MD (1)  ·  Bradley Allen, MD (1)  ·  Carol Kauffman, MD (1)  ·  Daniel Musher, MD (1)  ·  David Johnson, MD (1)  ·  David Rand, MD (1)  ·  James Grendell, MD (1)  ·  Julia Garcia-Diaz, MD (1)  ·  Partha Nandi, MD (1)  ·  Tom Snelling (1)  ·  Wesley Bray, MD (1)

Results publications

PMID 19133801